UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000054183 |
|---|---|
| Receipt number | R000061873 |
| Scientific Title | Ultrasound-guided selective glossopharyngeal nerve block and maxillary nerve block for postoperative analgesia after tonsillectomy: a single-center retrospective study |
| Date of disclosure of the study information | 2024/04/18 |
| Last modified on | 2024/04/18 11:47:36 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Ultrasound-guided selective glossopharyngeal nerve block and maxillary nerve block for postoperative analgesia after tonsillectomy: a single-center retrospective study
Acronym
Ultrasound-guided selective glossopharyngeal nerve block and maxillary nerve block for postoperative analgesia after tonsillectomy
Scientific Title
Ultrasound-guided selective glossopharyngeal nerve block and maxillary nerve block for postoperative analgesia after tonsillectomy: a single-center retrospective study
Scientific Title:Acronym
Ultrasound-guided selective glossopharyngeal nerve block and maxillary nerve block for postoperative analgesia after tonsillectomy: a single-center retrospective study
Region
| Japan |
Condition
Condition
tonsillectomy
Classification by specialty
| Anesthesiology | Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
In recent years, ultrasound-guided selective glossopharyngeal nerve block and ultrasound-guided maxillary nerve block have been reported to be effective for pain management after tonsillectomy. We retrospectively analyzed the effects of UGSGNB and UGMNB on the perioperative management of tonsillectomy under general anesthesia in adults.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
After recovery from general anesthesia, the patients were transferred to a surgical ward and received standard analgesic treatment with acetaminophen or NSAIDs. Information on the total opioid use, non-opioid analgesic use, and dietary intake were obtained from the patient's medical records.
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| 75 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
This retrospective study evaluated adults who underwent tonsillectomy under general anesthesia at Asahi General Hospital between January 2023 and February 2024.
Key exclusion criteria
Patients who meet any of the following conditions will not be included in this study:
1) Patients who have difficulty communicating due to intellectual disabilities or dementia
2) Other patients who are judged by the research director (co-investigator) to be unsuitable as research subjects.
Target sample size
30
Research contact person
Name of lead principal investigator
| 1st name | Yuki |
| Middle name | |
| Last name | Kojims |
Organization
Asahi General Hospital
Division name
Dental Anesthesiology
Zip code
289-2511
Address
I-1326, Asahi city
TEL
0479-63-8111
cojicoji1109@gmail.com
Public contact
Name of contact person
| 1st name | Yuki |
| Middle name | |
| Last name | Kojima |
Organization
Asahi General Hospital
Division name
Dental Anestheisology
Zip code
289-2511
Address
I-1326, Asahi Citry
TEL
0479-63-8111
Homepage URL
cojicoji1109@gmail.com
Sponsor or person
Institute
Asahi General Hospital
Institute
Department
Personal name
Funding Source
Organization
None
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Asahi General Hospital IRB
Address
I-1326, Asahi city
Tel
0479-63-8111
cojicoji1109@gmail.com
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2024 | Year | 04 | Month | 18 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2024 | Year | 01 | Month | 01 | Day |
Date of IRB
Anticipated trial start date
| 2024 | Year | 04 | Month | 01 | Day |
Last follow-up date
| 2024 | Year | 04 | Month | 30 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
None
Management information
Registered date
| 2024 | Year | 04 | Month | 18 | Day |
Last modified on
| 2024 | Year | 04 | Month | 18 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000061873
